WWS subjects carry loss-of-function FKRP mutations that fully disrupt α-DG glycosylation for laminin binding, causing clinically severe neuronal and muscle developmental damage and death following birth. The gene discussed is LAMB2; the disease is muscular dystrophy-dystroglycanopathy, type A.